Table 6.
Tenofovir treatment for chronic hepatitis B with severe acute exacerbation.
Authors | Design | Treatment (Patient Number) | HBV DNA (IU/mL) | Mortality (%) | p-Value | Prognostic Factors |
---|---|---|---|---|---|---|
Garg et al. [69] | Randomized study | TDF (14) | 7.5 × 105 | 43% | 0.03 | >2 log reduction in HBV DNA at 2 weeks |
Cotnrol group (13) | 1.7 × 106 | 85% |
TDF: tenofovir.